Allen & Overy announces half-year results for the period 1 May 2013 to 31 October 2013
Allen & Overy has announced its half-year financial results for the period 1 May 2013 to 31 October 2013.
Turnover is £608m, up 7.5 per cent on the same period last year (£566m). The results reflect a steady improvement in trading conditions in most markets, with particularly strong performances in London and across the Asia-Pacific region. The results are underpinned by improvements in the finance and litigation practices.
High-profile instructions over the past six months include the litigation practice being heavily engaged across New York, London and Hong Kong in dealing with the fast-moving foreign exchange probes; advising The Co-operative Bank and The Co-operative Group on the proposed recapitalisation of The Co-operative Bank; and advising the export credit agencies and commercial lenders on the $5bn (£3bn) financing for the $9bn Nghi Son Refinery and Petrochemical Project in Vietnam.
Other high-profile instructions include the first deal to be financed using ING and NIBC’s Pebble-commute financing structure; providing funding for the new €300m (£250m) Zaanstad Prison in the Netherlands; and instructing GlaxoSmithKline on the £1.35bn disposal of its nutritional drinks brands Lucozade and Ribena to Suntory Beverage & Food.
News from The Lawyer
Analysis from The Lawyer
At the time of its launch Accutrainee was described as a revolutionary change to the training model. Has it proved to be so? Not really.
Shearman & Sterling is making its presence felt in the City, squaring up to magic circle firms and looking to muscle in on key relationships. Private equity house Bridgepoint is one outfit that has had its head turned by the US firm.